Characteristics, Treatment, and Outcomes Associated with Clostridium difficile Associated Diarrhea in a Veterans Affairs Medical Center


We conducted a study to assess the characteristics, treatment and outcomes associated with Clostridium difficile associated diarrhea in a Veterans Affairs Medical Center. Fifty-eight consecutive individual cases of C. difficile infection in 2013 were observed within the Veterans Affairs New Jersey Health Care System (VA NJHCS). We molecularly typed all 58 individual strains and identified the associated characteristics, treatment and outcomes. Forty-four out of 58 specimens (76%) which were probed had characteristics of the epidemic strain BI/NAP1/027 making this virulent strain to be the predominate strain at the VA NJHCS. All C. difficile BI/NAP1/027 strains were resistant to fluoroquinolones and sensitive to fidaxomicin, metronidazole and vancomycin. Fidaxomicin had the most potent in vitro activity (MIC90 = 0.5 μg/ml) against the BI/NAP1/027 strain. Twenty-six of 44 patients (59%) with the virulent strain were from a long-term care facility (LTCF). Patients possessing the virulent strain from the LTCF had a mean APACHE II score of 14.1 and a predicted death rate of 21.9%. Two-third of patients were treated with metronidazole alone (mean APACHE II scores 9.6), and one-third required oral vancomycin and metronidazole (mean APACHE II scores 14.1). There were no C. difficile infection related deaths. C. difficile BI/NAP1/027, an epidemic strain, is the endemic strain at the VA NJHCS, but no increased mortality was seen with infection with this strain.

Share and Cite:

Huang, D. , Lee, H. and Chiang, T. (2014) Characteristics, Treatment, and Outcomes Associated with Clostridium difficile Associated Diarrhea in a Veterans Affairs Medical Center. Advances in Infectious Diseases, 4, 1-7. doi: 10.4236/aid.2014.41001.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Kazakova, S.V., Ware, K., Baughman, B., Bilukha, O., Paradis, A. and Sears, S. (2006) A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile. Archives of Internal Medicine, 166, 2518-2524.
[2] Johnson, S. and Gerding, D.N. (1998) Clostridium difficile-Associated Diarrhea. Clinical Infectious Diseases, 26, 1027-1034.
[3] Treating Disease with Microbes: Bugs in the System. The Economist 2012.
[4] Baxter, R., Ray, G.T. and Fireman, B.H. (2008) Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile-Associated Diarrhea in Hospitalized Patients. Infection Control and Hospital Epidemiology, 29, 44-50.
[5] Gifford, A.H. and Kirkland, K.B. (2006) Risk Factors for Clostridium difficile-Associated Diarrhea on an Adult Hematology-Oncology Ward. European Journal of Clinical Microbiology and Infectious Diseases, 25, 751-755.
[6] Palmore, T.N., Sohn, S., Malak, S.F., Eagan, J. and Sepkowitz, K.A. (2005) Risk Factors for Acquisition of Clostridium difficile-Associated Diarrhea among Outpatients at a Cancer Hospital. Infection Control and Hospital Epidemiology, 26, 680-684.
[7] Pepin, J., Valiquette, L., Alary, M.E., Villemure, P., Pelletier, A. and Forget, K. (2004) Clostridium difficile-Associated Diarrhea in a Region of Quebec from 1991 to 2003: A Changing Pattern of Disease Severity. Canadian Medical Association Journal, 171, 466-472.
[8] Loo, V.G., Poirier, L., Miller, M.A., Oughton, M., Libman, M.D., Michaud, S., Bourgault, A.M., Nguyen, T., Frenette, C., Kelly, M., Vibien, A., Brassard, P., Fenn, S., Dewar, K., Hudson, T.J., Horn, R., Rene, P., Monczak, Y. and Dascal, A. (2005) A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile-Associated Diarrhea with High Morbidity and Mortality. New England Journal of Medicine, 353, 2442-2449.
[9] McDonald, L.C., Killgore, G.E., Thompson, A., Owens Jr., R.C., Kazakova, S.V., Sambol, S.P., Johnson, S. and Gerding, D.N. (2005) An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. New England Journal of Medicine, 353, 2433-2441.
[10] McDonald, L.C. and Jernigan, D.B. (2004) Increasing Incidence of Clostridium difficile in U.S. Acute Care Hospitals 1993-2001. Proceedings of 14th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Philadelphia.
[11] McDonald, L.C. (2005) Clostridium difficile: Responding to a New Threat from an Old Enemy. Infection Control and Hospital Epidemiology, 26, 672-675.
[12] Bartlett, J.G. (2006) Narrative Review: The New Epidemic of Clostridium difficile-Associated Enteric Disease. Annals of Internal Medicine, 145, 758-764.
[13] Hubert, B., Loo, V.G., Bourgault, A.M., Poirier, L., Dascal, A., Fortin, E., Dionne, M. and Lorange, M. (2007) A Portrait of the Geographic Dissemination of the Clostridium difficile North American Pulsed-Field Type 1 Strain and the Epidemiology of C. difficile-Associated Disease in Quebec. Clinical Infectious Diseases, 44, 238-244.
[14] Cloud, J. and Kelly, C.P. (2007) Update on Clostridium difficile Associated Disease. Current Opinions in Gastroenterology, 23, 4-9.
[15] McEllistrem, M.C., Carman, R.J., Gerding, D.N., Genheimer, C.W. and Zheng, L. (2005) A Hospital Outbreak of Clostridium difficile Disease Associated with Isolates Carrying Binary Toxin Genes. Clinical Infectious Diseases, 40, 265-272.
[16] Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E. and McDonald, L.C. (2005) Toxin Production by an Emerging Strain of Clostridium difficile Associated with Outbreaks of Severe Disease in North America and Europe. Lancet, 366, 1079-1084.
[17] Rubin, M.S., Bodenstein, L.E. and Kent, K.C. (1995) Severe Clostridium difficile Colitis. Diseases of the Colon and Rectum, 38, 350-354.
[18] Clinical and Laboratory Standards Institute (2004) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. 6th Edition, Clinical and Laboratory Standards Institute, Wayne.
[19] Fawley, W.N. and Wilcox, M.H. (2002) Pulsed-Field Gel Electrophoresis Can Yield DNA Fingerprints of Degradation-Susceptible Clostridium difficile Strains. Journal of Clinical Microbiology, 40, 3546-3547.
[20] Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H. and Swaminathan, B. (1995) Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing. Journal of Clinical Microbiology, 33, 2233-2239.
[21] Tan, E.T., Robertson, C.A., Brynildsen, S., Bresnitz, E., Tan, C. and McDonald, C. (2007) Clostridium difficile-Associated Disease in New Jersey Hospitals, 2000-2004. Emerging Infectious Diseases, 13, 498-500.
[22] Harbarth, S., Samore, M.H. and Carmeli, Y. (2001) Antibiotic Prophylaxis and the Risk of Clostridium difficile-Associated Diarrhoea. Journal of Hospital Infections, 48, 93-97.
[23] Kuntz, J.L., Cavanaugh, J.E., Becker, L.K., Ward, M.A., Appelgate, D.M., Herwaldt, L.A. and Polgreen, P.M. (2007) Clostridium difficile-Associated Disease in Patients in a Small Rural Hospital. Infection Control and Hospital Epidemiology, 28, 1236-1239.
[24] Muto, C.A., Pokrywka, M., Shutt, K., Mendelsohn, A.B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystofiak, S., Patel-Brown, S., Pasculle, A.W., PAterson, D.L., Saul, M. and HArrison, L.H. (2005) A Large Outbreak of Clostridium difficile-Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use. Infection Control and Hospital Epidemiology, 26, 273-280.
[25] Mody, L.R., Smith, S.M. and Dever, L.L. (2001) Clostridium difficile-Associated Diarrhea in a VA Medical Center: Clustering of Cases, Association with Antibiotic Usage, and Impact on HIV-Infected Patients. Infection Control and Hospital Epidemiology, 22, 42-45.
[26] McCusker, M.E., Harris, A.D., Perencevich, E. and Roghmann, M.C. (2003) Fluoroquinolone Use and Clostridium difficile-Associated Diarrhea. Emerging Infectious Diseases, 9, 730-733.
[27] Carroll, D.N. (2003) Moxifloxacin-Induced Clostridium difficile-Associated Diarrhea. Pharmacotherapy, 23, 1517-1519.
[28] Gaynes, R., Rimland, D., Killum, E., Lowery, H.K., Johnson, T.M., Killgore, G. andTenover, F.C. (2004) Outbreak of Clostridium difficile Infection in a Long-Term Care Facility: Association with Gatifloxacin Use. Clinical Infectious Diseases, 38, 640-645.
[29] Changela, U., Cannon, J.P., Aneziokoro, C., Shah, P.S., Thottapurathu, L. and Lentino, J. (2004) Risk Factors and Mortality Associated with Clostridium difficile-Associated Diarrhoea at a VA Hospital. International Journal of Antimicrobial Agents, 24, 562-656.
[30] Chang, H.T., Krezolek, D., Johnson, S., Parada, J.P., Evans, C.T. and Gerding, D.N. (2007) Onset of Symptoms and Time to Diagnosis of Clostridium difficile-Associated Disease Following Discharge from an Acute Care Hospital. Infection Control and Hospital Epidemiology, 28, 926-931.
[31] Curry, S.R., Marsh, J.W., Muto, C.A., O’Leary, M.M., Pasculle, A.W. and Harrison, L.H. (2007) tcdC Genotypes Associated with Severe TcdC Truncation in an Epidemic Clone and Other Strains of Clostridium difficile. Journal of Clinical Microbiology, 45, 215-221.
[32] MacCannell, D.R., Louie, T.J., Gregson, D.B., Laverdiere, M., Labbe, A.C., Laing, R. and Henwick, S. (2006) Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada. Journal of Clinical Microbiology, 44, 2147-2152.
[33] Spigaglia, P. and Mastrantonio, P. (2002) Molecular Analysis of the Pathogenicity Locus and Polymorphism in the Putative Negative Regulator of Toxin Production (TcdC) among Clostridium difficile Clinical Isolates. Journal of Clinical Microbiology, 40, 3470-3475.
[34] Paltansing, S., van den Berg, R.J., Guseinova, R.A., Visser, C.E., van der Vorm, E.R. and Kuijper, E.J. (2007) Characteristics and Incidence of Clostridium difficile-Associated Disease in the Netherlands, 2005. Clinical Microbiology and Infections, 13, 1058-1064.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.